Information  X 
Enter a valid email address

Balfour Beatty PLC (BBY)

  Print      Mail a friend       Annual reports

Monday 02 December, 2019

Balfour Beatty PLC

Block listing Interim Review

RNS Number : 4068V
Balfour Beatty PLC
02 December 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 December 2019

 

Name of applicant:

Balfour Beatty plc

Name of scheme:

Conversion of Cumulative Redeemable Convertible Preference Shares of 1p each

Period of return:

From:

1 June 2019

To:

30 November 2019

Balance of unallotted securities under scheme(s) from previous return:

35,694,162 Ordinary Shares of 50p Each ("Ordinary Shares")

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

35,694,162 Ordinary Shares

 

 

 

 

 

 

Name of contact:

Ms A Fazal  

Telephone number of contact:

020 7216 6800

 

 Date: 2 December 2019

 

Name of applicant:

Balfour Beatty plc

Name of scheme:

Balfour Beatty Savings-Related Share Option Scheme

Balfour Beatty Executive Share Option Scheme

Period of return:

From:

1 June 2019

To:

30 November 2019

Balance of unallotted securities under scheme(s) from previous return:

319,148 Ordinary Shares

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

319,148 Ordinary Shares

 

 

 

 

 

 

Name of contact:

Ms A Fazal

Telephone number of contact:

020 7216 6800

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRBRBDDCXGBGCD

a d v e r t i s e m e n t